Back to News
Market Impact: 0.25
UBS Initiates Coverage of Solid Biosciences at Buy
Source: Nasdaq
Analyst InsightsHealthcare & Biotech
UBS initiated coverage of Solid Biosciences with a Buy recommendation on October 15, 2026. The stock closed at $5.74 that day, up from $5.46 on October 14; the article provides no further details on the one-week period.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
SLDB0.55
UBS0.00
More News
- Why is BE Semiconductor Industries stock sliding today?
- UBS cuts Six Flags stock price target to $18 on visitation concerns
- Halfway Through October, Diesel Is Setting the Terms for the Entire Energy Market
- BMO cuts C.H. Robinson stock price target on integration risks
- Here are the latest additions to UBS’ ’Pan-European Small & Mid-Cap’ list
- Six Flags price target cut at UBS after Georgia coaster death, but bank sees market overstating impact